RTI Surgical Inc. (NASDAQ:RTIX) shares traded up 2.5% during mid-day trading on Thursday . The company traded as high as $3.33 and last traded at $3.29, with a volume of 72,158 shares changing hands. The stock had previously closed at $3.21.

A number of research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of RTI Surgical from a “buy” rating to a “hold” rating in a research report on Wednesday, June 29th. Craig Hallum cut shares of RTI Surgical from a “buy” rating to a “hold” rating and dropped their target price for the company from $6.00 to $4.00 in a report on Thursday, July 28th.

The firm has a market cap of $191.80 million and a PE ratio of 46.76. The company’s 50 day moving average price is $3.39 and its 200 day moving average price is $3.70.

RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Wednesday, July 27th. The company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of $0.03 by $0.08. The firm earned $67.60 million during the quarter, compared to analysts’ expectations of $66.52 million. The business’s revenue was down 5.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.04 EPS. On average, equities analysts forecast that RTI Surgical Inc. will post $0.10 earnings per share for the current year.

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.